These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27618951)

  • 1. Increasing use of radical prostatectomy for locally advanced prostate cancer in the USA and Germany: a comparative population-based study.
    Hager B; Kraywinkel K; Keck B; Katalinic A; Meyer M; Zeissig SR; Scheufele R; Wirth MP; Huber J
    Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):61-66. PubMed ID: 27618951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated prostate cancer centers might cause an overutilization of radiotherapy for low-risk prostate cancer: A comparison of treatment trends in the United States and Germany from 2004 to 2011.
    Hager B; Kraywinkel K; Keck B; Katalinic A; Meyer M; Zeissig SR; Stabenow R; Froehner M; Huber J
    Radiother Oncol; 2015 Apr; 115(1):90-5. PubMed ID: 25770874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in prostate cancer incidence and treatment in USA.
    Lu-Yao GL; Greenberg ER
    Lancet; 1994 Jan; 343(8892):251-4. PubMed ID: 7905093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Locally advanced prostate cancer: a population-based study of treatment patterns.
    Lowrance WT; Elkin EB; Yee DS; Feifer A; Ehdaie B; Jacks LM; Atoria CL; Zelefsky MJ; Scher HI; Scardino PT; Eastham JA
    BJU Int; 2012 May; 109(9):1309-14. PubMed ID: 22085255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of prostate cancer survival in Germany and the USA: can differences be attributed to differences in stage distributions?
    Winter A; Sirri E; Jansen L; Wawroschek F; Kieschke J; Castro FA; Krilaviciute A; Holleczek B; Emrich K; Waldmann A; Brenner H;
    BJU Int; 2017 Apr; 119(4):550-559. PubMed ID: 27208546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival outcomes of locally advanced prostate cancer in patients aged < 50 years after local therapy in the contemporary US population.
    Sheng W; Zhang H; Lu Y
    Int Urol Nephrol; 2018 Aug; 50(8):1435-1444. PubMed ID: 29982959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radical prostatectomy for clinical T4 prostate cancer.
    Johnstone PA; Ward KC; Goodman M; Assikis V; Petros JA
    Cancer; 2006 Jun; 106(12):2603-9. PubMed ID: 16700037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of stage migration patterns between Europe and the USA: an analysis of 11 350 men treated with radical prostatectomy for prostate cancer.
    Gallina A; Chun FK; Suardi N; Eastham JA; Perrotte P; Graefen M; Hutterer G; Huland H; Klein EA; Reuther A; Montorsi F; Briganti A; Shariat SF; Roehrborn CG; de la Taille A; Salomon L; Karakiewicz PI
    BJU Int; 2008 Jun; 101(12):1513-8. PubMed ID: 18422773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the Rate of Adherence to International Guidelines for Androgen Deprivation Therapy with External-beam Radiation Therapy: A Population-based Study.
    Dell'Oglio P; Abou-Haidar H; Leyh-Bannurah SR; Tian Z; Larcher A; Gandaglia G; Fossati N; Shariat SF; Capitanio U; Briganti A; Montorsi F; Graefen M; Saad F; Karakiewicz PI
    Eur Urol; 2016 Sep; 70(3):429-35. PubMed ID: 26951945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival benefit of definitive therapy in patients with clinically advanced prostate cancer: estimations of the number needed to treat based on competing-risks analysis.
    Gandaglia G; Sun M; Trinh QD; Becker A; Schiffmann J; Hu JC; Briganti A; Montorsi F; Perrotte P; Karakiewicz PI; Abdollah F
    BJU Int; 2014 Dec; 114(6b):E62-E69. PubMed ID: 24467651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inverse stage migration in patients undergoing radical prostatectomy: results of 8916 European patients treated within the last decade.
    Budäus L; Spethmann J; Isbarn H; Schmitges J; Beesch L; Haese A; Salomon G; Schlomm T; Fisch M; Heinzer H; Huland H; Graefen M; Steuber T
    BJU Int; 2011 Oct; 108(8):1256-61. PubMed ID: 21244612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
    Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of marital status on stage and survival of prostate cancer patients treated with radical prostatectomy: a population-based study.
    Abdollah F; Sun M; Thuret R; Abdo A; Morgan M; Jeldres C; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI
    Cancer Causes Control; 2011 Aug; 22(8):1085-95. PubMed ID: 21643929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radical prostatectomy as primary treatment modality for locally advanced prostate cancer: a prospective analysis.
    Berglund RK; Jones JS; Ulchaker JC; Fergany A; Gill I; Kaouk J; Klein EA
    Urology; 2006 Jun; 67(6):1253-6. PubMed ID: 16678888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome.
    Ward JF; Slezak JM; Blute ML; Bergstralh EJ; Zincke H
    BJU Int; 2005 Apr; 95(6):751-6. PubMed ID: 15794776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ascertainment of postprostatectomy radiotherapy for prostate cancer in the Surveillance, Epidemiology, and End Results database.
    Wang K; Sheets NC; Basak R; Chen RC
    Cancer; 2016 Oct; 122(19):3069-74. PubMed ID: 27352280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A surveillance, epidemiology, and end results registry analysis of prostate cancer modality time trends by age.
    Terakedis BE; Rossi PJ; Liauw SL; Johnstone PA; Jani AB
    Am J Clin Oncol; 2010 Dec; 33(6):619-23. PubMed ID: 20051808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing the efficacy of radical prostatectomy in locally advanced prostate cancer.
    Altwein JE
    Urol Int; 1998; 60 Suppl 2():2-10; discussion 35. PubMed ID: 9607552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal timing of early versus delayed adjuvant radiotherapy following radical prostatectomy for locally advanced prostate cancer.
    Kowalczyk KJ; Gu X; Nguyen PL; Lipsitz SR; Trinh QD; Lynch JH; Collins SP; Hu JC
    Urol Oncol; 2014 Apr; 32(3):303-8. PubMed ID: 24321259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of locally advanced prostate cancer].
    Wirth MP; Hakenberg OW; Fröhner M
    Urologe A; 2005 Nov; 44(11):1295-302. PubMed ID: 16228167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.